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Abstract
Deoxynivalenol (DON), one of the most abundant mycotoxins found on cereals, is known to
be implicated in acute and chronic illnesses in both humans and animals. Among the symp-
toms, anorexia, reduction of weight gain and decreased nutrition efficiency were described,
but the mechanisms underlying these effects on feeding behavior are not yet totally under-
stood. Swallowing is a major motor component of ingestive behavior which allows the pro-
pulsion of the alimentary bolus from the mouth to the esophagus. To better understand
DON effects on ingestive behaviour, we have studied its effects on rhythmic swallowing in
the rat, after intravenous and central administration. Repetitive electrical stimulation of the
superior laryngeal nerve or of the tractus solitarius, induces rhythmic swallowing that can be
recorded using electromyographic electrodes inserted in sublingual muscles. Here we pro-
vide the first demonstration that, after intravenous and central administration, DON strongly
inhibits the swallowing reflex with a short latency and in a dose dependent manner. More-
over, using c-Fos staining, a strong neuronal activation was observed in the solitary tract
nucleus which contains the central pattern generator of swallowing and in the area post-
rema after DON intravenous injection. Our data show that DONmodifies swallowing and
interferes with central neuronal networks dedicated to food intake regulation.
Introduction
Mycotoxins are toxic fungal metabolites that contaminate a wide range of cereals and cereal-
derived products. Field fungi, such as the Fusarium species, produce mycotoxins on growing
cereals, but also during crop storage after harvesting [1]. Produced by various Fusarium fungi
species, Deoxynivalenol (DON) is the most abundant type B trichothecene found in cereals
such as wheat, maize, barley, oats, rye, and less often rice and banana [2]. DON is characterized
by a high stability under different environmental conditions and resistance to high temperature
[3] which explains its widespread presence in human food. In this context, DON constitutes
the most common contaminant of food stuffs [4–8]. The consumption of DON-contaminated
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cereals or cereal-derived products induces both acute and chronic toxic effets. In both humans
and farm animals, acute exposure to high doses causes nausea, vomiting, and drowsiness, and
may result in diarrhea, leukocytosis, gastrointestinal hemorrhage and ultimately death [9, 10].
Its capacity to induce vomiting episodes in various species including humans explains its com-
monly used nickname “vomitoxin” [11]. Exposure to moderate doses of this toxin induces
anorexia, reduced weight gain and altered nutritional efficiency [12]. Recent studies have
shown that DON reduces food intake and modifies satiation and satiety [13, 14]. This anorectic
action seems to imply a DON-induced release of the satiety gut hormone PYY [15] and the
activation of neuronal networks implicated in feeding behavior termination [14].
Swallowing is a major motor component of ingestive behavior, which allows the propulsion
of the alimentary bolus along the gut. These motor processes require the coordination of vari-
ous muscles localized in the mouth, larynx, pharynx and oesophagus. By propulsing food from
the oral cavity into the stomach via the pharynx and the oesophagus, this complex reflex con-
stitutes the first step of feeding behavior. The sensory afferent fibers convey through the supe-
rior laryngeal nerve (SLN), a branch of the vagus nerve, and project to the brainstem via the
solitary tract (ST) at the dorsal vagal complex (DVC) level. The afferent fibers, which play an
important role in triggering swallowing, contact premotoneurons mainly located within the
interstitial and intermediate subnuclei of the solitary tract nucleus (NTS) in the brainstem.
These premotoneurons, which modulate the motoneurons, constitute the central pattern gen-
erator of swallowing (SwCPG) [16]. Various neurotransmitter systems are involved in swallow-
ing [17]. The main data concern the induction and facilitation of SwCPG activity by excitatory
amino acids [18, 19], inhibition of the swallowing sequence by gaba amino butyric acid
(GABA) [20, 21], and the modulatory influence of monoamines [22]. In previous studies, we
have shown that the swallowing reflex is inhibited by anorexigenic substances such as leptin
[23] and brain derived neurotrophic factor (BDNF) [24]. Recently, Mostafeezur and al. [25]
reported that orexigenic cannabinoids facilitate the swallowing reflex. In this context, we
hypothesized that DON, which exerts a potent anorectic action, may regulate the swallowing
reflex. Based on this hypothesis, we evaluated the effect of intravenously (i.v.) or centrally
administered DON, on the swallowing reflex elicited by electrical stimulation of either the
peripheral SLN or the central ending of the afferent fibers localized in the ST. In both cases, the
stimulation implied the afferent fibers involved in the rhythmic swallowing reflex. Further, to
determine the central site of DON action, we investigated c-Fos expression induced by the
mycotoxin.
In the present study, we demonstrated that DON inhibits the swallowing reflex shortly after
its intravenous (i.v.) administration. A strong neuronal activation in the NTS and the area
postrema (AP), attested by an increased c-Fos expression, was also observed after i.v. injection.
Finally, the direct injection of DON within the SwCPG reduced rhythmic swallowing pattern.
Materials and Methods
The experimental procedures described here were carried out in accordance with the directives
of the French Ministry of Agriculture and Fisheries and the European Community Council
(86/609/EEC). The protocol was approved by the committee on the ethics of animal experi-
ments of Marseille/N°14 (authorization number: 01289.02).
1) Surgical procedures
Experiments were performed on 54 adult male Wistar rats weighing 350 g (Charles River, l’Ar-
bresle, France), anesthetized with 0.6ml of a mixture of ketamine (100 mg/ml; Centravet,
Dinan, France) and xylazine (15 mg/ml; Centravet, Dinan, France), injected intraperitoneally
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in a proportion of 90% and 10%, respectively. The anaesthesia was then continued by perfusion
of the same mixture diluted at 10%, through a catheter inserted in the femoral vein, at a rate of
0.01–0.05 ml/h.
Under supine position, the superior laryngeal nerve (SLN) was dissected free from sur-
rounding tissues and placed on miniature bipolar electrodes included in a plexiglas gutter. This
device was sutured to the adjacent muscles, then the cutaneous planes were sutured to well
maintain the stimulating device when the rat was fixed in a stereotaxic frame (Horsley and
Clarke apparatus adapted for rats) under prone position. After occipitoparietal craniotomy and
removal of the posterior part of the cerebellum, the floor of the fourth ventricle appeared to lie
in a horizontal plane. The surface of the medulla was exposed in order to allow the stereotaxic
introduction of the microelectrode in the NTS for drugs injection, and of the stimulatory bipo-
lar electrode into the ST. The medulla was covered with warm liquid paraffin.
2) Experimental procedures for DON injections
We studied how DON affects the rhythmic swallowing elicited by repetitive stimulations of the
SLN (or the ST). Previous studies have shown that a microinjection of glutamate within the
intermediate NTS, containing the SwCPG, can initiate swallowing [18, 23, 26]. Thus, glutamate
microinjection (1 fmol) was used as a control to check that the microelectrode was positioned
within the SwCPG. When such a glutamate microinjection elicited swallowing, the stereotaxic
coordinates were conserved for DON injections. The precise coordinates extended [23]
between 0.2–0.7 mm rostral to the caudal edge of the AP (taken as the 0) 0.5–0.7 mm laterally
and 0.4–0.8 mm in depth, roughly corresponding to those previously used. Fig 1A represents
the precise area of drug injections (from Paxinos and Watson [27]).
DON obtained from Sigma (Saint Quentin Fallavier, France) was dissolved in NaCl 0.9%
solution and delivered: i) in the SwCPG by pressure ejections through glass pipettes (70 μmO.
D. at the tip) using an injection device (PMI-200, Dagan Corp., Minneapoli, MN USA). The
pressure ejection was adjusted between 150 and 200 kPa for pulses of 3 seconds in duration,
and the injected volume was 100 nl. ii) in the femoral vein via a polyethylene catheter. The
injected volume was 500μl.
3) Stimulations and recordings
Swallowing was triggered by two different ways: i) peripheral stimulation of the sensitive fibers
contained in the SLN ii) central stimulation of the solitary tract (ST) corresponding to the
entering of the sensitive fibers in the brainstem. The main way to induce swallowing was SLN
stimulation. However, during the experiment, SLN stimulation could become less efficient. To
avoid increasing too much stimulation parameters, the ST stimulation (Fig 1A) was applied.
The bipolar electrode was lowered into the ST using stereotaxic coordinates, and an electrical
current was applied with parameters (voltage, duration) adjusted to that of the preceding SLN
stimulation until the rhythmic swallowing was induced. SLN and ST stimulation concerned
the same afferent fibers involved in the swallowing reflex.
Stimulation with a long train of pulses produced several swallows [or rhythmic swallowing
recorded by electromyography (EMG)], at a rhythm depending on stimulation frequency that
constitutes a specific pattern of swallowing. In the present study, repetitive long trains of pulses
(5 s duration at 5–30 Hz frequency every 30 s) were used. The pulse voltage, duration and fre-
quency varied according to the animal (1.5–5 V; 0.02–0.5 ms) in such a way as to trigger
around 4–6 rhythmic swallows. To monitor swallowing, the EMG activity of sublingual mus-
cles (mainly the geniohyoïd) was recorded by means of bipolar copper wire electrodes inserted
into the muscles, using a hypodermic needle. The respiratory activity was recorded by means
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Fig 1. A. Schematic representation of the brainstem at the DVC level showing the central pattern generator
of swallowing (SwCPG) and the solitary tract (ST). Coronal diagram of the medulla drawn from the atlas of
Paxinos andWatson [27] corresponding to the level of glutamate and DON injection sites (between 0.2 and
0.5 mm in front of the caudal edge of the area postrema and 0.5 to 0.7 mm lateral) and to the level of
stimulation of the solitary tract (ST). Although microinjections and ST stimulations were made on either side
of the medulla, all injection sites have been reported to the left side and dotted in the hatched area
corresponding to the region of the interstitial and intermediate solitary tract nucleus (NTS) subnuclei.
DON Inhibits Swallowing in Rat
PLOS ONE | DOI:10.1371/journal.pone.0133355 July 20, 2015 4 / 19
of a mechanotransducer placed around the thorax, and the electrocardiogram (ECG) by subcu-
taneous electrodes placed on each side of the thorax. Moreover, the electrocardiogram and
swallowing EMG signals were fed to loud speakers for auditory monitoring. Rectal temperature
was monitored and maintained around 37°C with a heating pad. The EMG, ECG and respira-
tion signals were recorded on a computer using an analog-to-digital interface (PowerLab 8SP
data acquisition software for Windows, ADInstruments, USA).
4) Signal Analysis
Either peripheral or central stimulations of afferent fibers triggered reflex swallowing. As an
example, repetitive electrical stimulation (every 30 s) of the SLN (2.5 V; 0.06 ms; 15 Hz, 5 s)
elicited rhythmic swallowing (Fig 1B). A stable control sequence involving three 5s trains of
stimulations was performed before DON injection. The mean values obtained during this
sequence were used as control values. Afterwards, stimulations and recordings were main-
tained until recovery.
The SLN or ST stimulation parameters produced a powerful cessation of respiration, which
accompanied rhythmic swallowing. A specially designed computer program Chart5.5 software
calculated:
R
EMG (electromyogram envelope signal normalized), Sw Number (number of
swallows triggered by SLN or ST stimulation), ECG and respiratory frequency.
5) Immunohistochemistry
PBS perfusion and immersion-fixation. Animals pretreated by DON (3mg/kg, iv, n = 5)
or by NaCl (0.9%, iv, n = 5) were used for c-Fos immunostaining. Two hours after injection,
rats under deep anesthesia, were perfused intracardially with 250ml of ice-cold 0.1M phosphate
buffered saline (PBS, pH 7.4). Rats were decapitated immediately; thereafter the brain extracted
from the skull was immersed into ice-cold freshly prepared solution of 4% paraformaldehyde
in 0.1M phosphate buffer (PB) overnight. Brains were rinsed in PBS and cryoprotected for 24–
48h in 30% sucrose at 4°C. The brains were frozen in isopentane (-40°C), then coronal sections
(40μm thick) of the brainstem were realized with a cryostat (Leica CM3050, France) and col-
lected serially in 0.1M PBS.
c-Fos immunohistochemistry. Brainstem sections were incubated for 10 minutes in 0.1M
PBS containing 1.5% H2O2 for quenching of endogenous peroxidase activity. After one hour in
saturation PBS buffer containing 3% normal goat serum and 0.3% triton X-100, sections were
incubated for 48h at 4°C with a rabbit anti-c-Fos antibody (1:10.000 Ab-5, Calbiochem). A bio-
tinylated goat anti-rabbit IgG (1:500, Vector Labs) was used as a secondary antibody (incu-
bated for 2h at room temperature). Peroxidase activity was revealed using the avidin-biotin
complex (1:200, Vector Labs) and diaminobenzidine as chromogen. Non-specific labelling was
observed on adjacent sections that were treated identically but without the primary antibody.
Histological micrographs illustrating the stimulating ST site show the bipolar electrode tract (see *). Amb,
ambiguous nucleus; AP, area postrema; OL, inferior olive; RVL, rostroventral reticular nucleus; SpT5, spinal
trigeminal tract; ST, solitary tract; 10, dorsal motor nucleus of the vagus; 12, hypoglossal nucleus; 12n,
hypoglossal nerve. B. Parameters recorded in the rat during the experiment. Stim, stimulation of the superior
laryngeal nerve (SLN), at 15 pulses/s during 5 s (pulse parameters: 2.5V and 0.06ms); EMG, sublingual
muscle electromyogram (note rhythmic swallowing triggered by SLN stimulation); ECG, electrocardiological
activity; Resp, respiration (note respiration blockade during SLN stimulation),
R
EMG, electromyogram
envelope signal normalized, Sw Number, number of swallows triggered by SLN stimulation; ECG Frequency
and Resp Frequency; “o” above the recording are event markers for ECG, Resp and EMG. Note that ST
stimulation produced similar responses.
doi:10.1371/journal.pone.0133355.g001
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The reaction was closely monitored and terminated by washing the sections in distilled water
when optimum intensity was obtained (3–5 min).
Image analysis and c-Fos positive neuron count. For each animal, c-Fos immunostaining
analysis was performed by counting the positive nuclei on four non-consecutive sections using
microphotographs acquired by a 10 fold lens with a DMX 1200 camera (Nikon) coupled to
ACT-1 software. The microscope was set at a specific illumination level, as was the camera
exposure time. c-Fos positive nuclei were then counted on these pictures by computer-assisted
morphometry using the ImageJ software as previously described by Girardet et al. [14].
6) Statistical analyses
All swallows calculated values were normalized as percents of control values. Statistical analy-
ses were performed using one- or two- way analysis of variance (ANOVA) followed by Fisher’s
protected least-significant difference post-hoc test for all electrophysiological data, and using
Mann-Whitney test for immunohistological data (StatView for Windows 5.0.1; SAS Institute).
Differences were considered significant when P< 0.05. Data were expressed as mean ± SEM.
Results
The results presented in this study come from the analysis of raw data summarized in S1 Table.
DON administered intravenously inhibited swallowing
Effects of DON were studied after intravenous administration on 24 rats from 32 trials. All
doses of DON induced a significant inhibition of the swallows recorded during SLN or ST
stimulation. At 3mg/kg body weight (bw) (14 rats, 16 trials) DON decreased the number of
swallows with a latency of 2.91 ± 1.45 min [Figs 2A and 3A, Table 1]. This effect was maximal
between 40 and 70 minutes after DON injection (32.1 ± 8.6 to 29.5 ± 8.4% decrease, P< 0.01)
and lasted 70.61 ± 4.43 min. At 1.5 mg/kg bw (4 rats, 7 trials), DON induced a significant
decrease in the number of swallows triggered by SLN or ST stimulation after a latency of
1.36 ± 0.42 min (Fig 3B and Table 1). Compared with the 3mg/kg dose, the effect presented
similar amplitude (31.7 ± 10.7% decrease, P< 0.01) but a shorter duration, 41.43 ± 9.20 min.
In the 6 tested rats (9 trials), injections of 0.3mg/kg bw DON decreased significantly the num-
ber of swallows 7 ± 1 min after the injection onset (23.4 ± 7.0%; P< 0.001) and this effect lasted
25.83 ± 7.64 min (Fig 3C and Table 1). Statistical comparison of the inhibitory effects of DON
doses (Fig 3D) showed that inhibition time course was significantly different only between
3mg/kg and 0.3mg/kg. The difference between the two doses became significant between 35
and 75 minutes after DON injection.
All doses of DON administered intravenously inhibited the rhythmic swallowing pattern,
without any variation of either cardiac frequency or respiratory activity (32 trials; 24 rats) (Fig
2B).
Effects of intravenous injection of DON on c-Fos expression in the
brainstem
Central structures activated in response to intravenous administration of DON were identified
using the immune detection of the c-Fos protein. A low basal level of c-Fos positive nuclei was
observed in the brainstem of control (NaCl) rats (Fig 4I). DON-treated rats exhibited a signifi-
cant increases in the number of c-Fos positive nuclei throughout the dorsal vagal complex
(DVC) including the nucleus tractus solitarius (NTS) and the area postrema (AP) (Fig 4II).
Counts of positive nuclei in the DVC revealed significant increases in the number of c-Fos
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Fig 2. Intravenously injected DON inhibited rhythmic swallowing triggered by SLN stimulation. A. Typical sublingual muscle electromyogram (note the
rhythmic swallowing induced by SLN stimulation). DON (3mg/kg bw) injection induced a rapid and powerful inhibition of the number of swallows. 3 minutes
after DON application, only three swallow were triggered by SLN stimulation. B. Electrocardiogram and respiratory activity recorded before, during and after
SLN stimulation. Note the blockade of respiration induced by swallowing during SLN stimulation in control condition and at recovery 74 min after DON
injection.
doi:10.1371/journal.pone.0133355.g002
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Fig 3. Dose-dependent DON inhibition of rhythmic swallowing triggered by SLN or ST stimulation.
Time course of the effect of various DON doses intravenously injected: 3mg/kg bw (16 trails; A), 1.5mg/kg bw
(7 trials, B) and 0.3mg/kg bw (9 trials; C) on the number of swallows recorded over 5 minute periods and until
recovery. On the right side of A and B, note a focus on the kinetics of DON effect over the first 5 min. Black
bars represent the mean value of the control recorded before DON injection (C, 100%). Data are represented
as means ± SEM normalized to the control value. D: Comparison of the inhibitory effects of the three doses of
DON on rhythmic swallowing triggered by SLN or ST stimulation. Note that time course variations according
DON Inhibits Swallowing in Rat
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labeled nuclei in treated animals compared with control animals. In DON-treated rats, we
observed a strong c-Fos induction in four sub-regions of the DVC: rostral part, postremal divi-
sion and caudal part of the NTS, and the AP (Fig 4AII, 4BII and 4CII). In DON treated rats, c-
Fos expression levels varied according to the sub-division of the DVC (Fig 4III): i) in the rostral
NTS, the mean number of c-Fos positive nuclei per section reached 895.95 ± 121.5 versus
272.85 ± 43.21 in control rats. ii) in the postremal NTS, the number of c-Fos positive nuclei
reached 1051.2 ± 72.16 versus 240.45 ± 30.9 in control rats. iii) in the caudal NTS, the number
of c-Fos positive nuclei reached 588.5 ± 125.69 versus 143.85 ± 39.8. iiii) in the AP the number
of c-Fos positive nuclei reached 190.5 ± 34.86 versus 38.75 ± 14.28 in control rats. The other
nuclei positively stained, ie the rostroventral reticular nucleus (RVL) and the inferior olive
(OL), exhibited no increase in c-Fos signals in response to DON administration (Fig 4DII,
4EII, and 4III).
DONmicroinjections within the SwCPG inhibited swallowing in a dose
dependent manner
The present results, obtained from 30 trials performed on 20 rats, showed that DONmicroin-
jections induced a significant dose-dependent decrease in the number of swallows recorded
during SLN (or ST) stimulation. At the 570ng/kg dose (10 trials, 9 rats), DON induced immedi-
ately a significant powerful decrease of swallows and this inhibition persisted during
43.35 ± 9.71min [Figs 5A and 6A, Table 1]. The maximal effects of DON occurred after 6s and
persisted during the 20 first minutes (68.4 ± 8.76% to 48.18 ± 11.5%, P< 0.0001 and
P< 0.001). At the 150ng/kg dose (10 trials, 6 rats), DON immediately induced a significant
powerful decrease of swallows and the inhibition persisted during 35.9 ± 4.63min [Fig 6B and
Table 1]. The maximal effects occurred immediately after DONmicroinjections and persisted
during 15 first minutes (60.8 ± 9.61% to 46.1 ± 10.3%, P< 0.001). In contrast, DON at the
60ng/kg dose (10 trials, 5 rats), failed to alter swallowing pattern characteristics, therefore this
DON dose could be considered as subthreshold in our experimental conditions [Fig 6C and
to the doses showed a significant inhibitory effect for DON 3mg/kg bw, compared with the other doses,
beginning 35 minutes after injection and lasting 40 minutes. *P<0.05, ** P<0.01, *** P<0.001, ****
P<0.0001.
doi:10.1371/journal.pone.0133355.g003
Table 1. Effects of DON injection on the real number of swallows triggered by SLN (or ST) stimulation.
i.v. DON dose Control Value After DON injection
3 mg/kg 4.9 ± 0.1 2.9 ± 0.4 (after 2min)
1.5 mg/kg 4.5 ± 0.2 2.8 ± 0.6 (after 2min)
0.3 mg/kg 4.1 ± 0.2 2.9 ± 0.4 (after 15min)
SwCPG DON dose Control Value 30s after DON injection
570 ng/kg 4.1 ± 0.3 1.2 ± 0.5
150 ng/kg 5.4 ± 0.2 2.3 ± 0.6
60 ng/kg 4.7 ± 0.2 3.7 ± 0.5
The real number of swallows recorded is indicated as mean ± sem. For each dose of DON injected, mean
values of swallows recorded at a time when a robust inhibitory effect of swallows was noted; except for
60ng/kg DON dose which did not modify the number of swallows. i.v., intravenous administration; SwCPG,
central microinjection.
doi:10.1371/journal.pone.0133355.t001
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Fig 4. Effects of DON intravenous administration on c-Fos immunoreactivity. Representative coronal
sections illustrating the c-Fos labeling observed in the brainstem (A, B, C: NTS, D: RVL, E: OL) of I) control
rats intravenously treated with NaCl (0.9%) and sacrificed 2h post-treatment, II) rats intravenously treated
with DON (3mg/kg bw) and sacrificed 2h post-treatment. III) Quantification of the number of c-Fos
immunoreactive nuclei in the brainstem observed in rats treated either with DON (3mg/kg bw) or NaCl (0.9%).
*P<0.05, **P<0.01 significantly different from NaCl-treated rats. Box explanation: upper horizontal line of
DON Inhibits Swallowing in Rat
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box, 3rd quartile; lower horizontal line of box, 1st quartile; color separation within box, median; upper
horizontal bar outside box, max; lower horizontal bar outside box, min. 4V, fourth ventricle; AP, area
postrema; cc, central canal; NTS-C, caudal part of the NTS; NTS-R, rostral part of the NTS; NTS-P,
postremal division of the NTS; OL, inferior olive; RVL, rostroventral reticular nucleus. Scale bar: 100 μm.
doi:10.1371/journal.pone.0133355.g004
Fig 5. DON (570ng/kg bw; 10 trials) microinjection within the central pattern generator of swallowing (SwCPG) inhibited rhythmic swallowing
triggered by SLN stimulation. A. Electromyogram from sublingual muscles (note the rhythmic swallowing induced by SLN stimulation). DONmicroinjection
at 570ng/kg bw induced a rapid and powerful inhibition of the number of swallows. 30 seconds after DON application, no more swallow was triggered by SLN
stimulation. This effect was transient since the swallows recovered after 45 minutes. B. Electrocardiogram and respiratory activity recorded during 30
seconds (before, during and after SLN stimulation). Note the blockade of respiration induced by swallowing during SLN stimulation in control condition and at
recovery 45 min after DON injection.
doi:10.1371/journal.pone.0133355.g005
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Fig 6. DONmicroinjection within the central pattern generator of swallowing (SwCPG) inhibited
rhythmic swallowing triggered by SLN or ST stimulation in a dose dependmanner. Time course of the
effects of various doses of DON: 570ng/kg bw (10 trials; A), 150ng/kg bw (10 trials; B), 60ng/kg bw (10 trials;
C) on the number of swallows recorded over 5 minute periods (for 570ng/kg bw and 150ng/kg bw) or over 30
second periods (for 60ng/kg bw). On the right side of A and B, note a focus on the kinetics of DON effect over
the first 5 min. Black bars represent the mean value of the control recorded before DON injection (C, 100%).
Data are represented as means ± SEM normalized to the control value. Note time course variations
DON Inhibits Swallowing in Rat
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Table 1]. Statistical comparison of the inhibitory effects of DON doses during the first 25 min-
utes after injection, showed a significant dose-dependent effect (Fig 6D). DON injected within
the SwCPG inhibited the rhythmic swallowing pattern, without any variation of either cardiac
frequency or respiratory activity (30 trials; 20 rats) (Fig 5B).
Discussion
The present study constitutes the first demonstration that DONmycotoxin inhibits the swal-
lowing reflex. Acute intravenous (i.v.) injection of increasing DON doses (0.3, 1.5 or 3 mg/kg)
transiently reduced the number of evoked swallows in a dose-dependent manner. The DON-
induced effect on swallowing appeared to be specific, since inhibition was never observed with
NaCl alone and DONmodified neither heart rate nor respiratory rhythm. The doses of DON
used here are classically employed to study acute intoxication in different models [28]. While
oral toxin administration mimics an ingestion of DON-contaminated feed, in the present
work, DON was intravenously administered on anaesthetized animals. Nonetheless, DON has
been shown to cross the gut barrier after ingestion [29, 30] and is found in the systemic circula-
tion after DON gavage [31, 32]. In our study, the duration of the inhibitory effect was dose-
dependent and the highest dose reduced swallowing for more than one hour. By allowing the
propulsion of the alimentary bolus along the gut, swallowing is a motor component of the
ingestive behavior and a process critical for normal food intake [16]. Thus, our results
strengthen the characterization of the DON effects on feeding behavior. DON ingestion
induces reduction of food intake and even emesis in different animal models. Eating naturally
contaminated food causes partial or complete feed refusal depending of the contamination
degree [33, 34]. Previously, we had shown that anorexigenic factors, such as the adipose tissue-
derived hormone leptin and the growth factor BDNF, inhibit the swallowing reflex [23, 24].
Inversely, Mostafeezur and al. [25] reported that orexigenic cannabinoids exert a facilitation of
the swallowing reflex. Hence, the present data allow to classify DON among anorexigenic sub-
stances that both decrease food intake and inhibit swallowing. To be complete, it should be
mentioned that this correlation between food intake and swallowing modulation is not quite as
straightforward as it seems since orexigenic compounds including ghrelin [35] and orexin [36]
were shown to inhibit the swallowing reflex.
One intriguing question is the mechanism by which intravenously injected DON inhibits the
swallowing reflex. Some arguments support the hypothesis of DON-induced systemic increase
in bioactive molecules that may act on peripheral targets. Among these putative effectors, sero-
tonin (5-HT) and its derivatives could be envisaged. The modulatory influence of monoamines
on the swallowing reflex is reported by several authors [16, 37] and 5-HT has well-known emetic
and food intake reducing effects [38]. The serotoninergic system was also proposed to play a
role in the triggering of feeding refusal, emesis and anorexia observed during DON intoxication
[39]. However, it was recently reported that, in minks, an elevation in 5-HT plasma concentra-
tion followed rather than preceded the emetic activity. Indeed, plasma 5-HT elevation was only
detectable 60 min after DON administration [40]. The kinetics of DON-induced inhibition of
the swallowing reflex (<5 min) weakens the hypothesis of a possible involvement of peripherally
released 5-HT. Otherwise, cytokines proinflammatory, which expression and release are
according to the doses showing a significant inhibitory effect immediately after DONmicroinjection for 570ng/
kg bw and 150ng/kg bw. At 60ng/kg bw, DONmicroinjection did not modify rhythmic swallowing triggered by
SLN stimulation. D: Comparison of the effects of the three doses of DON during the first 25 minutes after
injection. Note the powerful effect of 570ng/kg bw and 150ng/kg bw DON doses. *P<0.05, ** P<0.01, ***
P<0.001, **** P<0.0001.
doi:10.1371/journal.pone.0133355.g006
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increased by DON treatment may also be suggested [41]. These proinflammatory cytokines
could act directly on striated muscular fibers involved in swallowing or by a reflex pathway to
inhibit swallowing. Gaigé and al. [42] have shown, in the cat, that leptin enhances the intestinal
electromyographic activity via a long loop reflex involving intestinal vagal afferent fibers with a
release of Il-1ß. The superior laryngeal nerve being a branch of the vagus nerve, we can therefore
hypothesize that proinflammatory cytokines released during DON intoxication could activate
afferent fibers running in the SLN to change the activity of muscles involved in swallowing.
However, as mentioned above, the kinetics of DON-induced swallowing inhibition seems to be
poorly compatible with DON action on proinflammatory effectors. Even though oral exposure
to DON was shown to increase the expression of proinflammatory cytokines, these acute stimu-
latory effects were observed 2 h after treatment [39, 41, 43–45].
Although much of the present discussion focuses on a peripheral action of DON and on the
putative identity of peripheral effectors, it cannot be excluded that the toxin directly targets the
central nervous system (CNS) to modulate the swallowing reflex. Consistent with a possible
direct action of DON on the CNS, it was previously shown that the toxin is detectable in the
brain of mice within 5min of oral exposure [44]. Furthermore, we have recently demonstrated
that central DON injection mimics per os DON-induced anorexia [14]. In the present study,
we showed that i.v. injection resulted in a strong and significant increase in c-Fos expression
within the NTS and the AP. This DON-induced c-Fos expression was specific as it was not
found in other brainstem nuclei i.e. RVL and OL, structures activated by the movement of stri-
ated muscles consecutive to the stimulation procedure. When DON was injected intravenously,
its effects must have been larger than when injected in the SwCPG and in particular it may
have acted on the entire NTS involved in various autonomic functions. C-Fos data show neuro-
nal activation in various parts of the NTS involved in autonomic functions including respira-
tory and cardiac functions. However, electrophysiological data do not present any variations of
respiratory and cardiac activities. The data suggest that these functions were not affected by the
DON dose reaching the dedicated neurons. Moreover, in a previous study, Ngampongsa and
al. [46] showed that DON administrated subcutaneously caused changes in heart rate but only
90 minutes after injection. In our study, after the highest dose of DON administered intrave-
nously, swallowing was inhibited during 70 minutes and during these 70 minutes, we did not
find any variation of cardiac or respiratory activities. The immunostaining observed in the AP
is remarkable since this structure is a well-known pathway for systemic substances to reach the
brain. Ossenkopp and al. [47] reported that area postrema ablation prevents the systemic
DON-induced conditioned taste aversion in rats. These data suggest that the area postrema
could be a gateway through which DON reaches the brain. Interestingly, Willis and al. [48]
have shown that circulating compounds with a molecular weight about 0.3 kDa can diffuse
from the area postrema to surrounding nuclei (i.e. NTS). It should be noted that the molecular
weight of DON is 0.29 kDa. Moreover, the existence of vessels in the dorsomedial part of the
NTS that lack immunoreactivity for the blood-brain barrier markers was reported [49]. These
vessels may represent a route of entry for circulating substances to neurons in the NTS. All
these data suggest that part of intravenously administered DON could act at the brain level. To
investigate this assumption, we studied the effect of DONmicroinjections within the SwCPG.
They induced a transient significant inhibition of rhythmic swallowing. This inhibitory effect
appeared to be specific, since swallowing inhibition was never observed with NaCl alone. DON
microinjection is not an intracellular injection and may concern both the passage of axons and
NTS neurons surrounding the injection site. DON could indeed reach all these neural compo-
nents but in our experimental protocol, only the swallowing reflex was affected. Finally, while
the DVC is also an integrative center for autonomic cardiac and respiratory functions, the
highest DON dose affecting swallowing had no effect on heart rate or respiratory frequency,
DON Inhibits Swallowing in Rat
PLOS ONE | DOI:10.1371/journal.pone.0133355 July 20, 2015 14 / 19
confirming that DON specifically acts on ingestive functions rather than on other autonomic
functions.
The cellular mechanisms through which DON could modify neuronal activity leading to an
inhibition of the swallowing reflex are still unknown. Our study highlights the very short
latency of DON-induced swallowing inhibition after its central microinjection. To our knowl-
edge, this is the first description of such a rapid DON effect. To date, DON has been described
as a ribosome poison that disturbs this organite and in turn inhibits protein synthesis [39]. In
mice, per os DON administration inhibits protein synthesis in the spleen, peyer’s patches, kid-
ney, liver, intestine and plasma from 3 h to 9 h post-treatment [43]. It was recently suggested
that DON ribotoxic effect induces a modulation of mitogen activated protein kinases (MAPKs)
activity. In turn, MAPKs activation may result in transcription factor activation that induces
for instance cytokine or COX-2 expression [50–52]. It was also suggested that other signaling
factors such as double stranded RNA-activated protein kinase or hematopoietic cell kinase
relay DON toxicity from ribosome inhibition to MAPKs activation [53–55]. All these molecu-
lar mechanisms, which require minutes/hours delay to operate, appear poorly compatible with
the DON action described here. Indeed, we showed that DON inhibits the swallowing reflex
with a very short latency especially following central administration (<30 sec). It can be
reasonably envisaged that DONmight be able to induce rapid modulations of ionic conduc-
tance in neurons resulting in modifications of neuronal electrical activity. These alternative
mechanisms were already proposed to explain toxicity of other mycotoxins. T-2 toxin has been
shown to modify the activity of amino acid and glucose transporters, as well as calcium and
potassium channels on myoblast cell membrane [56]. This toxin was also shown to increase
cellular calcium concentration in the human promyelotic line HL-60 [57]. Whether such
mechanisms may account for the DON-induced swallowing inhibition remains to be tested.
Nevertheless, it appears from the present study that the electrophysiological recording of
rhythmic swallowing constitutes a suitable model to investigate this hypothesis.
In summary, the present study demonstrates that the food contaminating toxin, Deoxyniva-
lenol, inhibits the SwCPG in anesthetized rats and consequently the activity of motoneurons
involved in swallowing. After i.v. administration, we observed a strong c-Fos expression within
the NTS indicating an increased neuronal activity in this structure containing the SwCPG and
also within the AP, specific area involved in the crossing of peripheral substances to the brain.
Altogether, these data suggest an action of the toxin at the SwCPG level. Reinforcing this
assumption, we observed a striking inhibitory effect after DONmicroinjection within the
SwCPG.
Because this motor activity has a major role in ingestion, it can therefore be inferred that
DON inhibits ingestion by acting not only on the afferent and integrative components of the
structures involved in feeding but also on its motor outputs. The consequences of a DON-
induced swallowing modulation should be considered on vulnerable and predisposed individu-
als suffering from dysphagia or swallowing impairment.
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